Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083309 | SCV000253329 | likely benign | Charcot-Marie-Tooth disease dominant intermediate B | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000200560 | SCV000512830 | likely benign | not provided | 2018-09-19 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000200560 | SCV001143775 | benign | not provided | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000200560 | SCV001151637 | uncertain significance | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453722 | SCV002739384 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000200560 | SCV005879285 | likely benign | not provided | 2024-05-14 | criteria provided, single submitter | clinical testing |